Francis Burrows, the Chief Scientific Officer of $KURA, sold 23,726 shares of the company on 12-18-2025 for an estimated $231,931. We received data on the trade from a recent SEC filing. This was a sale of approximately 41.3% of their shares of this class of stock. Following this trade, they now own 33,735 shares of this class of $KURA stock.
$KURA Insider Trading Activity
$KURA insiders have traded $KURA stock on the open market 16 times in the past 6 months. Of those trades, 3 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $KURA stock by insiders over the last 6 months:
- TROY EDWARD WILSON (President and CEO) has made 3 purchases buying 100,000 shares for an estimated $713,346 and 1 sale selling 36,615 shares for an estimated $327,418.
- MOLLIE LEONI (Chief Medical Officer) has made 0 purchases and 2 sales selling 27,799 shares for an estimated $283,188.
- FRANCIS BURROWS (Chief Scientific Officer) sold 23,726 shares for an estimated $231,931
- BRIAN T. POWL (Chief Commercial Officer) has made 0 purchases and 2 sales selling 17,778 shares for an estimated $178,834.
- TERESA BROPHY BAIR (Chief Legal Officer) has made 0 purchases and 2 sales selling 17,609 shares for an estimated $177,137.
- KATHLEEN FORD (Chief Operating Officer) has made 0 purchases and 2 sales selling 13,794 shares for an estimated $138,772.
- FAHEEM HASNAIN sold 10,000 shares for an estimated $109,764
- THOMAS JAMES DOYLE (SVP, Finance & Accounting) has made 0 purchases and 2 sales selling 9,080 shares for an estimated $91,338.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$KURA Hedge Fund Activity
We have seen 123 institutional investors add shares of $KURA stock to their portfolio, and 94 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RA CAPITAL MANAGEMENT, L.P. removed 4,004,610 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $23,106,599
- ECOR1 CAPITAL, LLC removed 3,327,500 shares (-79.2%) from their portfolio in Q3 2025, for an estimated $29,448,375
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 2,627,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $15,157,789
- GOLDMAN SACHS GROUP INC added 1,681,056 shares (+180.0%) to their portfolio in Q3 2025, for an estimated $14,877,345
- ARMISTICE CAPITAL, LLC removed 1,528,000 shares (-24.6%) from their portfolio in Q3 2025, for an estimated $13,522,800
- AQR CAPITAL MANAGEMENT LLC added 1,300,517 shares (+138.1%) to their portfolio in Q3 2025, for an estimated $11,509,575
- JACOBS LEVY EQUITY MANAGEMENT, INC added 1,121,228 shares (+101.6%) to their portfolio in Q3 2025, for an estimated $9,922,867
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$KURA Analyst Ratings
Wall Street analysts have issued reports on $KURA in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 11/24/2025
- UBS issued a "Buy" rating on 11/14/2025
- Wedbush issued a "Outperform" rating on 11/14/2025
- JMP Securities issued a "Market Outperform" rating on 10/20/2025
- HC Wainwright & Co. issued a "Buy" rating on 09/30/2025
- Cantor Fitzgerald issued a "Overweight" rating on 06/26/2025
To track analyst ratings and price targets for $KURA, check out Quiver Quantitative's $KURA forecast page.
$KURA Price Targets
Multiple analysts have issued price targets for $KURA recently. We have seen 5 analysts offer price targets for $KURA in the last 6 months, with a median target of $28.0.
Here are some recent targets:
- Etzer Darout from Barclays set a target price of $28.0 on 11/24/2025
- Robert Driscoll from Wedbush set a target price of $38.0 on 11/14/2025
- David Dai from UBS set a target price of $16.0 on 11/14/2025
- Joseph Pantginis from HC Wainwright & Co. set a target price of $40.0 on 10/20/2025
- Reni J. Benjamin from JMP Securities set a target price of $24.0 on 10/20/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
